These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14993470)

  • 1. Copolymer 1: an off-beat drug development story.
    Scheindlin S
    Mol Interv; 2004 Feb; 4(1):6-9. PubMed ID: 14993470
    [No Abstract]   [Full Text] [Related]  

  • 2. Copolymer 1 from the laboratory to FDA.
    Teitelbaum D; Sela M; Arnon R
    Isr J Med Sci; 1997 Apr; 33(4):280-4. PubMed ID: 9347880
    [No Abstract]   [Full Text] [Related]  

  • 3. Translating new insights into treatment optimisation in multiple sclerosis.
    Fazekas F; Kieseier BC
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S1-2. PubMed ID: 19200857
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes.
    Wiendl H; Hohlfeld R
    Neurology; 2009 Mar; 72(11):1008-15. PubMed ID: 19289741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The copolymer-1 story so far.
    Fricker J
    Lancet; 1998 Jun; 351(9118):1792. PubMed ID: 9635963
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH
    Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glatiramer acetate in the treatment of multiple sclerosis.
    Miller AE
    Neurol Clin; 2005 Feb; 23(1):215-31, viii. PubMed ID: 15661095
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glatiramer for relapsing-remitting multiple sclerosis].
    Hennemann A
    Med Monatsschr Pharm; 2002 Apr; 25(4):141-2. PubMed ID: 12017128
    [No Abstract]   [Full Text] [Related]  

  • 9. Does the flap of a butterfly's wings in Brazil set off a tornado in Texas?--The JC Virus Story in multiple sclerosis.
    Achiron A; Miron S; Shoenfeld Y
    Isr Med Assoc J; 2005 May; 7(5):283-5. PubMed ID: 15909458
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple sclerosis: from immunopathogenesis to disease management].
    Nervenarzt; 1996 Dec; 67(12 Suppl Von Der Im):1-8. PubMed ID: 9403091
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of glatiramer acetate in the treatment of multiple sclerosis.
    Wolinsky JS
    Adv Neurol; 2006; 98():273-92. PubMed ID: 16400839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and MRI effects of Glatirameracetate].
    Nervenarzt; 1999 Aug; 70(8 Suppl):1-8. PubMed ID: 10511871
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple sclerosis poses tough drug development challenges.
    Senior K
    Drug Discov Today; 2005 Dec; 10(23-24):1583-4. PubMed ID: 16376813
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current studies of the effects of immunosuppressive agents on multiple sclerosis].
    Minderhoud JM
    Ned Tijdschr Geneeskd; 1989 Jan; 133(3):99-100. PubMed ID: 2646546
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for use of glatiramer acetate in multiple sclerosis.
    Comi G; Hartung HP; Martinelli Boneschi F
    Lancet Neurol; 2005 Feb; 4(2):75-6; discussion 76-7. PubMed ID: 15664539
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for use of glatiramer acetate in multiple sclerosis.
    Caramanos Z; Arnold DL
    Lancet Neurol; 2005 Feb; 4(2):74-5; discussion 76-7. PubMed ID: 15664538
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic trials for multiple sclerosis.
    McKhann GM
    Ann Neurol; 1990 Jun; 27(6):589-90. PubMed ID: 2193612
    [No Abstract]   [Full Text] [Related]  

  • 18. [Status and perspective in the therapy of multiple sclerosis. C. Prevention of relapses and of progression].
    Pöhlau D
    Krankenpfl J; 1997 Mar; 35(3):69-71. PubMed ID: 9136384
    [No Abstract]   [Full Text] [Related]  

  • 19. New options for early treatment of multiple sclerosis.
    Tintoré M
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S9-S11. PubMed ID: 19200870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cop 1 therapy for multiple sclerosis.
    Weiner HL
    N Engl J Med; 1987 Aug; 317(7):442-4. PubMed ID: 3302706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.